Merck Sharp & Dohme B.V. v. Warner Chilcott Company LLC et al
| Merck Sharp & Dohme B.V. |
| Warner Chilcott Company LLC and Warner Chilcott (US) LLC |
| Warner Chilcott Company LLC and Warner Chilcott (US) LLC |
| Merck Sharp & Dohme B.V. |
| 1:2013cv02088 |
| December 24, 2013 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX Outside US |
| Gregory M. Sleet |
| Patent |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
145
MEMORANDUM OPINION. Signed by Judge Gregory M. Sleet on 8/26/2016. (mdb)
|
|
Filing
138
ORDER - As used in the asserted claims of the '581 patent, "physiologically required amount" is construed to mean "the amounts of the progestogenic compound and the estrogenic compound required by the body to achieve the full therapeutic effect.". Signed by Judge Gregory M. Sleet on 2/25/2016. (mdb)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
